You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
智飛生物(300122.SZ):定增不超1億股批文到期失效
格隆匯 12-31 01:18

格隆匯12月31日丨智飛生物(300122.SZ)公佈,公司於2019年9月18日收到中國證監會出具的《關於核准重慶智飛生物製品股份有限公司非公開發行股票的批覆》(證監許可〔2019〕1184號),核准公司非公開發行不超過1億股新股,自核準發行之日(2019年7月2日)起6個月內有效。

取得批覆後,公司董事會一直積極推進此次非公開發行股票的發行事宜,由於相關法規、政策及融資環境等發生變化,此次發行工作在中國證監會核准發行之日起6個月內尚未完成,該批文到期自動失效。

此次非公開發行股票批文到期失效不會對公司的生產經營活動造成重大影響。根據相關規定,公司後續如再推出股權融資計劃,需重新召開董事會和股東大會審議發行方案,並按規定進行披露後上報中國證監會核准。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account